Overview

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

Status:
Completed
Trial end date:
2018-07-16
Target enrollment:
Participant gender:
Summary
Multi-centre study of HTL0018318 in patients with Alzheimer's disease as an add-on to standard-of-care
Phase:
Phase 1
Details
Lead Sponsor:
Heptares Therapeutics Limited
Collaborator:
Allergan